BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24210582)

  • 1. Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
    Roux C; Thyss A; Gari-Toussaint M
    J Mycol Med; 2013 Dec; 23(4):270-3. PubMed ID: 24210582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia.
    Karia S; Jeyapalan K; Kennedy B
    Br J Haematol; 2011 Apr; 153(2):147. PubMed ID: 21332707
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia.
    Henn A; Mellon G; Benoît H; Roos-Weil D; Jauréguiberry S; Mordant P; Fekkar A; Caumes E
    Scand J Infect Dis; 2014 Mar; 46(3):231-4. PubMed ID: 24450842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients.
    Eketorp Sylvan S; Lundin J; Ipek M; Palma M; Karlsson C; Hansson L
    Ann Hematol; 2014 Oct; 93(10):1725-33. PubMed ID: 24844780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
    Pitini V; Cascio A; Arrigo C; Altavilla G
    Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal aspergillosis after liver transplant: Report of an unusual case.
    Araos-Baeriswyl E; Moll-Manzur C
    Gastroenterol Hepatol; 2018 Jan; 41(1):30-31. PubMed ID: 28089360
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal abscess due to Aspergillus fumigatus as the only sign of disseminated aspergillosis in a patient with AIDS.
    Metta H; Corti M; Redini L; Bruggesser F; Arechavala A; Negroni R; Veliz L
    Rev Iberoam Micol; 2010 Sep; 27(3):136-9. PubMed ID: 20346298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suppurative thyroiditis and perineal subcutaneous abscess related with aspergillus fumigatus: a case report and literature review.
    Tan J; Shen J; Fang Y; Zhu L; Liu Y; Gong Y; Zhu H; Hu Z; Wu G
    BMC Infect Dis; 2018 Dec; 18(1):702. PubMed ID: 30587135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Reda G; Maura F; Gritti G; Gregorini A; Binda F; Guidotti F; Piciocchi A; Visco C; Rodeghiero F; Cortelezzi A
    Am J Hematol; 2012 Sep; 87(9):936-7. PubMed ID: 22718434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
    Laros-van Gorkom BA; Huisman CA; Wijermans PW; Schipperus MR
    Neth J Med; 2007 Oct; 65(9):333-8. PubMed ID: 17954952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
    Saadeh CE; Srkalovic G
    Pharmacotherapy; 2008 Feb; 28(2):281-4. PubMed ID: 18225973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab for B-cell chronic lymphocytic leukemia.
    Robak T
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1033-51. PubMed ID: 18588450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
    Miyamoto Y; Sakamoto Y; Ohuchi M; Tokunaga R; Shigaki H; Kurashige J; Iwatsuki M; Baba Y; Yoshida N; Watanabe M; Baba H
    Anticancer Res; 2016 Feb; 36(2):821-3. PubMed ID: 26851046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia.
    Ng A; Gadong N; Kelsey A; Denning DW; Leggate J; Eden OB
    Pediatr Hematol Oncol; 2000 Sep; 17(6):497-504. PubMed ID: 10989471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
    Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for alemtuzumab treatment in chronic lymphocytic leukaemia (CLL)].
    Smolej L; Procházka V; Špaček M; Obrtlíková P; Gumulec J; Vokurka S; Doubek M;
    Vnitr Lek; 2012 Mar; 58(3):232-6. PubMed ID: 22486291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alemtuzumab in chronic lymphocytic leukemia.
    James DF; Kipps TJ
    Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
    Agbetile J; Bourne M; Fairs A; Hargadon B; Desai D; Broad C; Morley J; Bradding P; Brightling CE; Green RH; Haldar P; Pashley CH; Pavord ID; Wardlaw AJ
    J Allergy Clin Immunol; 2014 Jul; 134(1):33-9. PubMed ID: 24290286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.